We first evaluated ERBB2 gene expression by reverse transcription polymerase chain reaction (RT–PCR) in 24 tumor samples obtained at baseline with ≥30% of tumor cells (Extended Data Fig. 7). The gene discussed is ERBB2; the disease is neoplasm.